During the past decade, Unified Women's Clinical Research - Raleigh conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 8 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Unified Women's Clinical Research - Raleigh" #1 sponsor was "Bayer" with 6 trials, followed by "Scynexis, Inc." with 4 trials sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Cidara Therapeutics Inc." with 2 trials sponsored and "Abbott Molecular" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unified Women's Clinical Research - Raleigh" #1 collaborator was "Agility Clinical, Inc." with 1 trials as a collaborator, "Chemo Research" with 1 trials as a collaborator, "Clinical Research Management, Inc." with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Unified Women's Clinical Research - Raleigh" are "Hot Flashes" (3 trials), "Candida Vulvovaginitis" (2 trials), "Candidiasis, Vulvovaginal" (2 trials), "Contraception" (2 trials) and "Endometriosis" (2 trials). Many other conditions were trialed in "Unified Women's Clinical Research - Raleigh" in a lesser frequency.

Most popular intervention types in "Unified Women's Clinical Research - Raleigh" are "Drug" (16 trials), "Device" (4 trials), "Biological" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Vilaprisan (BAY1002670)" (4 trials), "Fluconazole" (2 trials), "Ibrexafungerp" (2 trials) and "fezolinetant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Unified Women's Clinical Research - Raleigh" are 23 trials for "Female" genders.

Currently, there are NaN active trials in "Unified Women's Clinical Research - Raleigh". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Unified Women's Clinical Research - Raleigh, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Unified Women's Clinical Research - Raleigh, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".